Adaptive Drug Delivery Systems for Niche Environments

Publication ID: 24-11857758_0004_PTD
Published: November 07, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Drug Delivery Systems for Niche Environments,” Published Technical Disclosure No. 24-11857758_0004_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857758_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,758.

Summary of the Inventive Concept

This inventive concept adapts the original drug delivery device for specific, high-stakes operational environments, such as high-security areas, disaster relief zones, and extreme weather conditions, to provide timely and effective opioid overdose treatment.

Background and Problem Solved

The original drug delivery device, while effective in general settings, may not be suitable for unique operational environments where medical personnel may be limited or unavailable. This inventive concept addresses the need for specialized drug delivery systems that can operate reliably in these niche environments.

Detailed Description of the Inventive Concept

The new claims introduce four specialized variations of the original drug delivery device, each tailored to a specific environment. The first variation incorporates a biometric sensor to detect opioid overdoses in high-security areas. The second variation uses a solar-powered battery to operate in remote disaster relief zones. The third variation features a waterproof housing and temperature-resistant drug reservoir to function in extreme weather conditions. The fourth variation establishes a network of implantable drug delivery devices that communicate with a central server to detect overdoses and automatically release medication in areas with limited medical infrastructure.

Novelty and Inventive Step

The new claims introduce novel adaptations of the original drug delivery device, including the use of biometric sensors, solar-powered batteries, waterproof housings, and networked devices, which provide a non-obvious solution to the problem of opioid overdose treatment in niche environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of other biometric sensors, such as ECG or blood oxygen level sensors, or the integration of additional features, such as GPS tracking or remote monitoring capabilities, to further enhance the device's functionality in niche environments.

Potential Commercial Applications and Market

The adaptive drug delivery systems for niche environments have significant commercial potential in industries such as emergency response, disaster relief, and high-security facilities, as well as in areas with limited medical infrastructure, providing a new avenue for opioid overdose treatment and prevention.

CPC Classifications

SectionClassGroup
A A61 A61M5/14276
A A61 A61B5/4839
A A61 A61B5/4845
A A61 A61B5/4848
A A61 A61K9/0024
A A61 A61K9/0097
A A61 A61M5/44
A A61 A61M31/002
A A61 A61M37/0069
A A61 A61B5/01
A A61 A61F2250/0068
A A61 A61K31/485

Field of Art

Medical Device Technology, Specifically Drug Delivery Systems and Emergency Medical Intervention Technologies, Encompassing Implantable Devices, Sensor Integration, and Automated Medication Delivery

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in medical device design, sensor integration, embedded systems, and drug delivery mechanisms, possessing knowledge of miniaturized electronics, biocompatible materials, and emergency medical intervention technologies

Obviousness Rationale

A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's core drug delivery device concept, applying standard engineering design techniques to adapt the device for specialized environments. The fundamental mechanism of implantable drug delivery remains consistent, with the variations representing incremental improvements using known technological approaches. The modifications demonstrate standard problem-solving strategies within medical device engineering, utilizing readily available sensor, power, and communication technologies.

Obvious Combinations & Variations

Source Patent Element
Implantable drug delivery device with reservoir for naloxone/epinephrine
PTD Variation
Biometric sensor integration for overdose detection
Obviousness Reasoning
Adding physiological monitoring sensors is a predictable design enhancement in medical implant technologies, representing a known technique for improving device responsiveness and diagnostic capabilities
Source Patent Element
Single-use drug delivery device with temporary seal
PTD Variation
Waterproof housing for extreme environmental conditions
Obviousness Reasoning
Adapting medical devices for environmental resilience is a standard engineering approach, utilizing known materials and sealing techniques to extend operational parameters
Source Patent Element
Drug reservoir containing specific emergency medications
PTD Variation
Solar-powered battery system for remote deployment
Obviousness Reasoning
Implementing alternative power sources is a routine design optimization, particularly for remote medical devices, representing a finite set of predictable engineering solutions
Source Patent Element
Method of detecting physiological reactions to overdose
PTD Variation
Networked communication between multiple implantable devices
Obviousness Reasoning
Expanding single-device functionality to a networked system represents a logical technological progression using standard communication protocols and distributed sensing approaches
Source Patent Element
Implantable drug delivery method for emergency intervention
PTD Variation
GPS tracking and central server integration
Obviousness Reasoning
Incorporating location tracking and centralized monitoring represents a predictable enhancement using established telecommunications and medical monitoring technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857758, the present publication demonstrates that the claimed variations in drug delivery device design represent obvious modifications to the prior art, employing standard engineering techniques and predictable technological combinations that would be readily apparent to a person having ordinary skill in medical device technologies. The disclosed adaptations constitute prima facie obviousness under 35 U.S.C. ยง 103, rendering subsequent claims involving similar technological approaches anticipated and unpatentable.

Original Patent Information

Patent NumberUS 11,857,758
TitleDrug delivery device and method
Assignee(s)Purdue Research Foundation